Essa Pharma Inc (EPIX)

05:46 AM

Why ESSA Pharma Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser

05:46 AM

04:40 AM

ESSA Pharma Inc. Stock Analysis and ForecastTremendous return on equity - PrintWeekIndia

04:40 AM

02:21 AM

Will ESSA Pharma Inc. stock benefit from interest rate changesMarket-leading growth rates - jammulinksnews.com

02:21 AM

01:05 AM

What analysts say about ESSA Pharma Inc. stockFree Trading Strategy Suggestions - Autocar Professional

01:05 AM

12:10 PM

Class Action Filed Against ESSA Pharma Inc. (EPIX)March 25, 2025 Deadline to JoinContact The Gross Law Firm - MarketScreener

12:10 PM

Jul 23, 2025

What drives ESSA Pharma Inc. stock priceTurbocharged investment results - Autocar Professional

Jul 23, 2025

Jul 23, 2025

ESSA Pharma Seeks Court Approval for Cash Distribution Amid XenoTherapeutics Merger - TipRanks

Jul 23, 2025

Jul 23, 2025

ESSA Pharma to seek court approval for cash distribution to shareholders - Investing.com Australia

Jul 23, 2025

Jul 23, 2025

ESSA Pharma Plans $1.91 Per Share Distribution Before XenoTherapeutics MergerCourt Hearing Set - Stock Titan

Jul 23, 2025

Jul 23, 2025

ESSA Pharma to be Acquired by XenoTherapeutics in All-Cash Deal - TipRanks

Jul 23, 2025

Jul 23, 2025

Is ESSA Pharma Inc. a good long term investmentSky-high profits - Autocar Professional

Jul 23, 2025

Jul 16, 2025

ESSA Pharma to Be Acquired by XenoTherapeutics - Global Legal Chronicle

Jul 16, 2025

Jul 15, 2025

How ESSA Pharma Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser

Jul 15, 2025

Jul 15, 2025

What makes ESSA Pharma Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 15, 2025

Jul 15, 2025

XenoTherapeutics to acquire ESSA Pharma in deal backed by XOMA Royalty - Canadian Lawyer Magazine

Jul 15, 2025

Jul 15, 2025

ESSA Pharma to be acquired by XenoTherapeutics in all-cash deal - Investing.com Australia

Jul 15, 2025

Jul 14, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX) - TradingView

Jul 14, 2025

Jul 14, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX) - GlobeNewswire Inc.

Jul 14, 2025

Jul 14, 2025

EPIX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of ESSA Pharma Inc. is Fair to Shareholders - Business Wire

Jul 14, 2025

Jul 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jul 14, 2025

Jul 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (NasdaqMGRM), Veritex Holdings, Inc. (NasdaqVBTX), ESSA Pharma Inc. (NasdaqEPIX), Waters Corporation (NYSEWAT - Morningstar

Jul 14, 2025

Jul 14, 2025

ESSA Pharma Enters into a Business Combination Agreement with XenoTherapeutics - MarketScreener

Jul 14, 2025

Jul 14, 2025

EPIX SEC FilingsEssa Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 14, 2025

Jul 14, 2025

ESSA Pharma to be Acquired by XenoTherapeutics, Backed by XOMA Royalty - citybiz

Jul 14, 2025

Jul 14, 2025

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired b - GuruFocus

Jul 14, 2025

Jul 14, 2025

ESSA Pharma to be Acquired by XenoTherapeutics - TipRanks

Jul 14, 2025

Jul 14, 2025

Essa Pharma Inc. announces definitive agreement to be acquired by Xenotherapeutics, Inc., backed by XOMA Royalty Corporation in all-cash transaction - MarketScreener

Jul 14, 2025

Jul 14, 2025

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction - The Globe and Mail

Jul 14, 2025